Development of a broad-spectrum nasal live attenuated influenza vaccine based on mosaic antigen design against influenza B viruses
Xue Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuelong Shu(Sun Yat-sen University), Qi Chen(Fujian Normal University), Lin Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Tian Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Xuejie Liu(Shenzhen University), Yuhang Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongwei Chen(Liaoning Shihua University), Chen Chen(Nanjing Agricultural University), Ximeng Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhuolin Yang(Shenzhen University), Rui Ma(Jiangsu Normal University), Jian Lü(National Institute for Viral Disease Control and Prevention), Lifang Yuan(Chinese Academy of Sciences), Tianyi Zhao(Shenzhen University), Wenfei Zhu(Southern Medical University), Wang Pang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuhang Shi(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 2
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
|Journal of Infection|2020|1.2k
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
|New England Journal of Medicine|2013|698
Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study
|The Lancet|2014|663
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
|Nature Communications|2014|422